QT Vascular in US$13.14m convertible debt investment to fund growth
Published Fri, Jul 24, 2015 · 10:53 AM
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.
This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.
On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Worst days for China’s stock market may be over
Emerging-market optimism dashed by Fed as currencies, bonds sink
LHN warns H1 2024 net profit could decline by 28.6%
It is time to put idle cash back into the market
Gauging sentiment is crucial, and there are hard and easy ways to do it
iPhone maker Hon Hai’s April sales rise 19% in positive signal